The largest database of trusted experimental protocols

Elisa microplate reader

Manufactured by Agilent Technologies
Sourced in United States, China, Germany

The ELISA microplate reader is a laboratory instrument used to measure the absorbance of light in microplate wells. It is designed to detect and quantify the presence of specific molecules in liquid samples, such as proteins, antibodies, or enzymes, through the use of enzyme-linked immunosorbent assay (ELISA) techniques.

Automatically generated - may contain errors

171 protocols using elisa microplate reader

1

Cell Viability Assay with MSNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMMs were seeded into 96-well plates at a density of 1 × 104 cells/well and allowed to adhere overnight. Different MSNs or MSNs-ISL concentrations (i.e., 16 and 64 μg/mL) with 30 ng/mL M-CSF were added, and the cells were cultured for the indicated time points (24, 48, or 72 h). Cell viability was evaluated using Cell Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan) according to the manufacturer's protocol. Cells were incubated with 100 μL of fresh α-MEM containing 10 μL of CCK-8 reagent, and the absorbance of all wells at 450 nm was assessed using an ELISA microplate reader (Bio-Tek Instruments Inc., Winooski, VT, USA).
+ Open protocol
+ Expand
2

Cell Proliferation Assay with XTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell Proliferation Kit II (XTT, Roche, CA, USA) was used in the evaluation of cell proliferation/survival. The cells were seeded into 96-well plates (1 × 103 cells/well) for 24 h and then treated with palbociclib or AZD4547 (or in combination) at the indicated concentrations for 5 days. XTT reagent was then incubated with the cells for four hours at 37 °C. The colorimetric absorbance was measured with an ELISA microplate reader (BioTek; Winooski, VT, USA) at 450 nm. Six parallel replicates were analyzed for each experimental sample. Representative data from three sets of repeats were presented.
+ Open protocol
+ Expand
3

Cytotoxicity Evaluation of Pseudane-VII

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity was measured by colorimetric MTT assay. RAW 264.7 cells (2 × 104 cells/well) in complete medium were seeded into a 96-well cell culture plate; various concentrations of pseudane-VII (0 to 100 μM) were added to the wells, and the plate was incubated in 37 °C for 24 h. After treatment, medium containing pseudane-VII was removed and MTT (0.5 mg/mL) solution was added to each well. After incubation in 37 °C for 4 h, MTT solution was removed and the formazan product was dissolved in solvent (1:1 = dimethyl sulfoxide:ethanol) resulting in a colored solution. Absorbance of the formazan solution was measured at 570 nm using an ELISA microplate reader (BioTek, Winooski, VT, USA).
+ Open protocol
+ Expand
4

ATRA's Impact on H9c2 Cell Viability Post-H/R Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
A previous study revealed that ATRA could facilitate the proliferation of H9c2 cells in normal condition [16 (link)]. In the present study, the effect of ATRA on H9c2 cell viability after H/R injury was evaluated using a WST-1 assay. Briefly, 1 × 104 cells were seeded, per well, in 96-well culture plates (passage 6~10, ~3 × 104 cells per cm2) and incubated for 24 h. ATRA, in 10-fold serial dilutions from 100 μM to 1 nM in DMSO, was added to the culture medium and allowed to incubate for 24 h. DMSO equivalent to ATRA at the highest concentration served as an H/R group. Control refers to cells with neither H/R injury nor ATRA treatment. After H/R treatment, 10 μM of WST-1 cell proliferation assay reagent was added to each well and allowed to incubate for 3.5 h (Roche Applied Science, Mannheim, Germany). Absorbance was read at 450 nm using an enzyme-linked immunosorbent assay (ELISA) microplate reader (BioTek, VT, U.S.).
+ Open protocol
+ Expand
5

Evaluating Inflammatory Cytokine Levels in LPS-Stimulated BV2 Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
BV2 microglia cells were treated with lipopolysaccharide (LPS; 1 µg/mL) for 4 h, after which they were incubated with or without MCC950 for 2 h before stimulation with ATP (1 mM) for 24 h. Levels of IL-1β, IL-18, and TNF in the culture medium were measured using an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s protocol. Briefly, the 96-well microplates were coated overnight with anti-IL-1β, anti-IL-18, or anti-TNF antibody then blocked with 1% bovine serum albumin (BSA). Standards or culture medium (100 µL) were added to the microplates and incubated at room temperature for 2 h; this was followed first by incubation for 2 h with the biotin-conjugated detection antibody then by incubation for 30 min with 100 µL of streptavidin–horseradish peroxidase plus substrate for signal development. Finally, 100 µL of stop solution was added to each well and the OD450 was measured using an ELISA microplate reader (Bio-Tek Instruments, Winooski, VT, USA) [30 ].
+ Open protocol
+ Expand
6

Keratinocyte Viability Assay for Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MTT assay was used to examine the effects of the fruit and medicinal herb extracts on human keratinocytes viability. Human keratinocytes were cultured in a 96-well plate (1×104 cells/well) for 24 h at 37°C with 5% CO2. Next, the cells were treated with the fruit and medicinal herb extracts (200 μg/mL) for 24 h and then incubated with 100 μL of MTT reagent (5 mg/mL) for 1 h. Then, the reaction medium was removed and the insoluble formazan remaining in the keratinocytes was dissolved in 100 μL of DMSO at room temperature for 15 min. The absorbance of each well was measured at 540 nm using an ELISA microplate reader (BioTek Instruments, Inc., Winooski, VT, USA). The viability of the fruit and medicinal herb extract-treated cells was expressed as a percentage of the viability of untreated cells.
+ Open protocol
+ Expand
7

Neuroprotective Effects of Platycodigenin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Embryos were removed from a pregnant ICR mouse at 14 days of gestation as described previously [13 (link)]. For neuronal viability assay, the cells were seeded in a 96-well plate at a density of 20,000 cells per well for 3 d. Then, the neurons were treated with 10 μM Aβ25-35 (Sigma-Aldrich, A4559) or cotreated with platycodigenin (Chengdu Desite Biotech Co. Ltd, Chengdu, China) for 3 days. The Aβ25-35 was previously incubated at 37 °C for 4 days for aggregation. Neurons were then incubated with 10 μL of CCK-8 solution (MCE, HY-K0301) for 3 h. The fluorescent absorbances were measured at 450 nm using an ELISA microplate reader (Biotek, Winooski, VT, USA). For normal neurite density measurement, the cells were seeded in an 8-well plate at a density of 10,000 cells per well for 2 d. Then the neurons were treated with PLA (0.01–10 μM) for 4 d. For Aβ treated neurite density measurement, the neurons were treated with 10 μM Aβ25-35 for 3 days before being treated with platycodigenin for 4 days. The cells were then prepared for immunocytochemistry.
+ Open protocol
+ Expand
8

ELISA-based Antibody Titer Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibody titer of serums was identified by ELISA with RBMFP being coated as an antigen and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG MAb being used as a secondary antibody. First, purified RBMFP protein in carbonate coating buffer at a final concentration of 10 μg/mL was coated at 100 μL/well on the 96-well ELISA plates at 4°C overnight, and the unbound molecules were then washed 3 times by PBST. After a blocking step with 5% defatted milk at 37°C for 2 h and 3 PBST rinses were performed, serums from each week that were diluted in PBS with a 10 times gradient ratio (102 ~107) were added at 100 μL/well and incubated at 37°C for 2 h. Then the plates were washed 3 times with PBST. After the wash step, the HRP-conjugated goat anti-mouse IgG MAb (1:5,000; MultiScience, Hangzhou, China) was added at 100 μL/well, reacted at 37°C for 2 h, and then rinsed with PBST. Then, the chromogenic tetramethylbenzidine (TMB; Innoreagents, Huzhou, China) solution was added at 100 μL/well and incubated at 37°C for 10 min. Finally, 50 μL/well of the ELISA stop solution (Beyotime, Beijing, China) was added, and the absorbance (optical density [OD]) at 450 nm was measured in a Bio-Tek ELISA microplate reader. The antibody titer of the serums was evaluated and statistically analyzed by GraphPad Prism 8.0 software.
+ Open protocol
+ Expand
9

Cytokine Levels in Animal Exudates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exudates from the animals’ air pouch were used to measure cytokines levels (IL-1β and TNF-α), using commercial Enzyme-Linked Immunosorbent Assay kits ELISA (R&D Systems, Minneapolis, MN, USA), according to the manufacturer’s protocol. Results were obtained using an ELISA microplate reader (Epoch, BioTek®, Winooski, VT, USA) at 450 nm and expressed in ng/mL.
+ Open protocol
+ Expand
10

Glucose-Induced Cytotoxicity in HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs were seeded at a density of 5 × 104 cells/well in 24-well plate and incubated with various concentrations of glucose (5.5, 15, 30 and 60 mM) in the presence or absence of ADC or RES for 24-72 h. After treatment, the amount of LDH in the HUVEC culture media was determined according to the manufacturer’s instruction. The LDH activity was measured at 440 nm using an ELISA microplate reader (Bio-Tek Instruments).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!